INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

77,421 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
4
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
6,349 sh
Apr 13, 2026
Page 1143 of 1936
← PrevNext →
Apr 15, 2026
traded Apr 13, 2026
+2d
SEC Form 4

Evidence

4
HM
Hoffmann MartinCEO
ONONOn Holding AG
Open-market sale · 10b5-1 plan
SELL$141K
4,150 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

4
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Derivative conversion · 10b5-1 plan
C—
11.00M sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

4
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Open-market sale · 10b5-1 plan
SELL$99K
767 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

4
SM
Slessor MikeDirector, CEO
FORMFORMFACTOR INC
Open-market sale · 10b5-1 plan
SELL$229K
1,826 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

4
ML
Mater Tonya L.SVP & Chief Accounting Officer
EPREPR PROPERTIES
Open-market sale · 10b5-1 plan
SELL$147K
2,600 sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

3
CM
Craig Jonathan M.MD, Head of Retail Investing
SCHWSCHWAB CHARLES CORP
Option exercise · 10b5-1 plan
M—
21.8K sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

2
PJ
Prober Charles J.Director
LIFLife360, Inc.
Option exercise · 10b5-1 plan
M$89K
7,930 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

1
SE
Susi Roger E.Director, CEO, President, Chairman, 10% Owner
IRMDIRADIMED CORP
Open-market sale · 10b5-1 plan
SELL$170K
1,847 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

1
SE
Susi Roger E.Director, CEO, President, Chairman, 10% Owner
IRMDIRADIMED CORP
Open-market sale · 10b5-1 plan
SELL$55K
589 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

1
SE
Susi Roger E.Director, CEO, President, Chairman, 10% Owner
IRMDIRADIMED CORP
Open-market sale · 10b5-1 plan
SELL$197K
2,107 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

1
SE
Susi Roger E.Director, CEO, President, Chairman, 10% Owner
IRMDIRADIMED CORP
Open-market sale · 10b5-1 plan
SELL$238K
2,564 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
IJ
Inrig JulaCHIEF MEDICAL OFFICER
TVTXTravere Therapeutics, Inc.
Grant or award · 10b5-1 plan
A—
14.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$59K
4,167 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
16.7K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
SE
Susi Roger E.Director, CEO, President, Chairman, 10% Owner
IRMDIRADIMED CORP
Open-market sale · 10b5-1 plan
SELL$37K
393 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

0
SD
Spector DavidDirector, Chairman & CEO
PFSIPennyMac Financial Services, Inc.
Open-market sale · 10b5-1 plan
SELL$39K
417 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

0
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
900.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
100.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
Yuan Eric S.Director, Chief Executive Officer
ZMZoom Communications, Inc.
Derivative conversion · 10b5-1 plan
C—
69.9K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
225.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
6,250 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
MJ
Murtagh Nigel JChief Risk Officer
SCHWSCHWAB CHARLES CORP
Option exercise · 10b5-1 plan
M—
41.3K sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

0
Yuan Eric S.Director, Chief Executive Officer
ZMZoom Communications, Inc.
Derivative conversion · 10b5-1 plan
C—
15.3K sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$36K
3,542 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$6,857
6,349 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
Yuan Eric S.Director, Chief Executive Officer
ZMZoom Communications, Inc.
Derivative conversion · 10b5-1 plan
C—
15.3K sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

0
RE
Rote William E.Chief Research Officer
TVTXTravere Therapeutics, Inc.
Grant or award · 10b5-1 plan
A—
14.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
Siebel Thomas MDirector, Executive Chairman, 10% Owner
AIC3.ai, Inc.
Option exercise · 10b5-1 plan
M—
165.3K sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
4,167 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
16.7K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
KL
Kutua LubiCFO, Treasurer
BYNDBEYOND MEAT, INC.
Tax withholding · 10b5-1 plan
F$797
1,208 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
900.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
VM
Venturo Brian MDirector, Chief Strategy Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
225.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
PJ
Prober Charles J.Director
LIFLife360, Inc.
Option exercise · 10b5-1 plan
M—
7,930 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Derivative conversion · 10b5-1 plan
C—
11.00M sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
16.7K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
6,250 sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Grant or award · 10b5-1 plan
A—
64.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
100.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC Form 4

Evidence